Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 2
2006 1
2007 1
2008 5
2009 5
2010 2
2011 3
2013 4
2015 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis C virus infection increases autophagosome stability by suppressing lysosomal fusion through an Arl8b-dependent mechanism.
Jones-Jamtgaard KN, Wozniak AL, Koga H, Ralston R, Weinman SA. Jones-Jamtgaard KN, et al. Among authors: ralston r. J Biol Chem. 2019 Sep 27;294(39):14257-14266. doi: 10.1074/jbc.RA119.008229. Epub 2019 Aug 5. J Biol Chem. 2019. PMID: 31383738 Free PMC article.
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus.
Liu D, Tedbury PR, Lan S, Huber AD, Puray-Chavez MN, Ji J, Michailidis E, Saeed M, Ndongwe TP, Bassit LC, Schinazi RF, Ralston R, Rice CM, Sarafianos SG. Liu D, et al. Among authors: ralston r. Viruses. 2019 Nov 8;11(11):1039. doi: 10.3390/v11111039. Viruses. 2019. PMID: 31717338 Free PMC article.
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Kwong AD, Najera I, Bechtel J, Bowden S, Fitzgibbon J, Harrington P, Kempf D, Kieffer TL, Koletzki D, Kukolj G, Lim S, Pilot-Matias T, Lin K, Mani N, Mo H, O'Rear J, Otto M, Parkin N, Pawlotsky JM, Petropoulos C, Picchio G, Ralston R, Reeves JD, Schooley RT, Seiwert S, Standring D, Stuyver L, Sullivan J, Miller V; Forum for Collaborative Human Immunodeficiency Virus Research; HCV Drug Development Advisory Group (HCV DRAG); Sequence Analysis Working Group (SAWG); Phenotype Analysis Working Group (PAWG). Kwong AD, et al. Among authors: ralston r. Gastroenterology. 2011 Mar;140(3):755-60. doi: 10.1053/j.gastro.2011.01.029. Epub 2011 Jan 19. Gastroenterology. 2011. PMID: 21255574 No abstract available.
The conundrum of relapse in STAT-C therapy: does HCV play the Red Queen or Rip Van Winkle?
Ralston R, Jacobson I, Scull M. Ralston R, et al. Semin Liver Dis. 2011 Nov;31(4):410-9. doi: 10.1055/s-0031-1297929. Epub 2011 Dec 21. Semin Liver Dis. 2011. PMID: 22189980 Review.
Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3.
Tumurbaatar B, Tikhanovich I, Li Z, Ren J, Ralston R, Kuravi S, Campbell R, Chaturvedi G, Huang TT, Zhao J, Hao J, O'Neil M, Weinman SA. Tumurbaatar B, et al. Among authors: ralston r. Am J Pathol. 2013 Dec;183(6):1803-1814. doi: 10.1016/j.ajpath.2013.08.013. Epub 2013 Nov 11. Am J Pathol. 2013. PMID: 24225087 Free PMC article.
Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approach.
Liu D, Ji J, Ndongwe TP, Michailidis E, Rice CM, Ralston R, Sarafianos SG. Liu D, et al. Among authors: ralston r. Antimicrob Agents Chemother. 2015;59(6):3482-92. doi: 10.1128/AAC.00223-15. Epub 2015 Apr 6. Antimicrob Agents Chemother. 2015. PMID: 25845863 Free PMC article.
Imaging-based assay for identification and characterization of inhibitors of CXCR4-tropic HIV-1 envelope-dependent cell-cell fusion.
Kramer S, Buontempo P, Agrawal S, Ralston R. Kramer S, et al. Among authors: ralston r. J Biomol Screen. 2011 Jul;16(6):668-75. doi: 10.1177/1087057111403480. Epub 2011 Apr 7. J Biomol Screen. 2011. PMID: 21474836
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor.
Arasappan A, Bennett F, Bogen SL, Venkatraman S, Blackman M, Chen KX, Hendrata S, Huang Y, Huelgas RM, Nair L, Padilla AI, Pan W, Pike R, Pinto P, Ruan S, Sannigrahi M, Velazquez F, Vibulbhan B, Wu W, Yang W, Saksena AK, Girijavallabhan V, Shih NY, Kong J, Meng T, Jin Y, Wong J, McNamara P, Prongay A, Madison V, Piwinski JJ, Cheng KC, Morrison R, Malcolm B, Tong X, Ralston R, Njoroge FG. Arasappan A, et al. Among authors: ralston r. ACS Med Chem Lett. 2010 Feb 15;1(2):64-9. doi: 10.1021/ml9000276. eCollection 2010 May 13. ACS Med Chem Lett. 2010. PMID: 24900178 Free PMC article.
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.
Gu Z, Graci JD, Lahser FC, Breslin JJ, Jung SP, Crona JH, McMonagle P, Xia E, Liu S, Karp G, Zhu J, Huang S, Nomeir A, Weetall M, Almstead NG, Peltz SW, Tong X, Ralston R, Colacino JM. Gu Z, et al. Among authors: ralston r. Antimicrob Agents Chemother. 2013 Jul;57(7):3250-61. doi: 10.1128/AAC.00527-13. Epub 2013 Apr 29. Antimicrob Agents Chemother. 2013. PMID: 23629699 Free PMC article.
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy.
Demers GW, Johnson DE, Tsai V, Wen SF, Quijano E, Machemer T, Philopena J, Ramachandra M, Howe JA, Shabram P, Ralston R, Engler H. Demers GW, et al. Among authors: ralston r. Cancer Res. 2003 Jul 15;63(14):4003-8. Cancer Res. 2003. PMID: 12873998 Free article.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback